Gazette.govt.nzPursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicines set out in the Schedule hereto:
Schedule
| Product: | Noradrenaline Tartrate |
| Active Ingredient: | Noradrenaline acid tartrate monohydrate 0.12g/L equivalent to noradrenaline base 0.06g/L |
| Dosage Form: | Solution for infusion |
| New Zealand Sponsor: | Biomed Limited |
| Manufacturer: | Biomed Limited, Auckland, New Zealand |
| Note: This renewed consent is valid for two years from 2 December 2019. | |
| Product: | Noradrenaline Tartrate |
| Active Ingredient: | Noradrenaline acid tartrate monohydrate 0.199g/L equivalent to noradrenaline base 0.1g/L |
| Dosage Form: | Solution for infusion |
| New Zealand Sponsor: | Biomed Limited |
| Manufacturer: | Biomed Limited, Auckland, New Zealand |
| Note: This renewed consent is valid for two years from 2 December 2019. | |
| Product: | Noradrenaline Tartrate |
| Active Ingredient: | Noradrenaline acid tartrate monohydrate 0.239g/L equivalent to noradrenaline base 0.12g/L |
| Dosage Form: | Solution for infusion |
| New Zealand Sponsor: | Biomed Limited |
| Manufacturer: | Biomed Limited, Auckland, New Zealand |
| Note: This renewed consent is valid for two years from 2 December 2019. | |
| Product: | Noradrenaline Tartrate |
| Active Ingredient: | Noradrenaline acid tartrate monohydrate 0.319g/L equivalent to noradrenaline base 0.16g/L |
| Dosage Form: | Solution for infusion |
| New Zealand Sponsor: | Biomed Limited |
| Manufacturer: | Biomed Limited, Auckland, New Zealand |
| Note: This renewed consent is valid for two years from 2 December 2019. | |
Dated this 27th day of September 2019.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).